Vasoactive intestinal peptide producing pheochromocytoma and intracardiac thrombosis.
Thrombus
hypercoagulability
pheochromocytoma
vasoactive intestinal peptide
Journal
Rare tumors
ISSN: 2036-3605
Titre abrégé: Rare Tumors
Pays: England
ID NLM: 101526926
Informations de publication
Date de publication:
2021
2021
Historique:
received:
26
01
2021
accepted:
15
03
2021
entrez:
23
4
2021
pubmed:
24
4
2021
medline:
24
4
2021
Statut:
epublish
Résumé
A case of pheochromocytoma producing vasoactive intestinal peptide (VIP) and left ventricular thrombus in the absence of cardiomyopathy or wall motion abnormalities on echocardiogram is presented along with a review of the relevant literature. A 30-year-old female of Afghani descent with past medical history of panic attacks presented with fever, cough, sore throat, vomiting, and was found to have an 11 cm adrenal mass consistent with primary adrenocortical adenoma versus carcinoma. Her tumor elicited catechols and vasoactive intestinal peptide. Her hospitalization was complicated by left ventricular thrombosis leading to an embolic injury to her right kidney, respiratory failure, need for transient dialysis and urinary tract infections. She developed a profuse secretory diarrhea and decision was made to treat with empiric octreotide infusion and imodium with improvement in symptoms. She underwent coil and particle embolization followed by resection. Followup PET gallium scan showed no evidence of residual disease or metastasis. VIP producing pheochromocytoma associated with intracardiac thrombosis is rare. Outcomes depend on prompt diagnosis of the pheochromocytoma and multidisciplinary approach to management.
Identifiants
pubmed: 33889374
doi: 10.1177/20363613211007792
pii: 10.1177_20363613211007792
pmc: PMC8040591
doi:
Types de publication
Case Reports
Langues
eng
Pagination
20363613211007792Informations de copyright
© The Author(s) 2021.
Déclaration de conflit d'intérêts
Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
World J Gastroenterol. 2007 Sep 14;13(34):4649-52
pubmed: 17729424
Jpn J Clin Oncol. 2005 Sep;35(9):559-63
pubmed: 16027147
J Med Case Rep. 2011 Jul 13;5:310
pubmed: 21752274
BMC Cancer. 2014 Jul 31;14:553
pubmed: 25081061
Ann Intern Med. 2001 Feb 20;134(4):315-29
pubmed: 11182843
South Med J. 2000 Nov;93(11):1093-5
pubmed: 11095560
J Cardiothorac Vasc Anesth. 2002 Jun;16(3):338-43
pubmed: 12073207
Am J Med. 1987 Oct;83(4):773-6
pubmed: 3674065
World J Clin Cases. 2018 Nov 26;6(14):862-868
pubmed: 30510956
J Hum Hypertens. 2003 May;17(5):349-52
pubmed: 12756408
Kidney Blood Press Res. 2006;29(5):321-6
pubmed: 17119341
J Vasc Surg. 2005 Sep;42(3):570-2
pubmed: 16171610
Nephrol Dial Transplant. 2000 May;15(5):717-8
pubmed: 10809818
Clin Pharm. 1989 Apr;8(4):255-73
pubmed: 2653711
Mayo Clin Proc. 2002 Jan;77(1):97-100
pubmed: 11795252
J Pain Symptom Manage. 2010 Jul;40(1):142-8
pubmed: 21634046
Horm Res. 2008;70(3):188-92
pubmed: 18663320
Rev Esp Cardiol. 2005 May;58(5):598-600
pubmed: 15899204
Crit Rev Oncol Hematol. 2007 May;62(2):126-36
pubmed: 17293122
Endocr Pract. 2014 Aug;20(8):e145-50
pubmed: 24936559
Intern Med. 2009;48(12):1015-9
pubmed: 19525590